Clinical Trial

Connective Tissue Matrix for Rotator Cuff Tendinopathy

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to determine if the effectiveness of a single injection of CTM Boost in the treatment of patients with rotator cuff tendinopathy (RCT) is as effective as a single injection of platelet rich plasma (PRP) in reducing the symptoms of RCT.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-11-29; most recent amendment 2025-09-02.
Status change: Recruiting → Active, Not Recruiting 2025-09-02
Status change: Not Yet Recruiting → Recruiting 2024-03-14
Trial Details
NCT Number NCT06160427
Lead Sponsor Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Collaborators: Connective Tissue Matrix Biomedical, LLC
Conditions Tendinopathy, Shoulder Pain, Rotator Cuff Tendinitis, Rotator Cuff Tendinosis
Enrollment 92 participants
Start Date 2023-12-04
Primary Completion 2027-01-15 (estimated)
Study Completion 2028-01-15 (estimated)
Updated on ClinicalTrials.gov 2025-09-08